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Abstract Cyclic adenosine 3, 50-monophosphate (cAMP) is
a ubiquitous second messenger regulating many biological
processes, such as cell migration, differentiation, prolifera-
tion and apoptosis. cAMP signaling functions not only on the
plasma membrane, but also in the nucleus and in organelles
such as mitochondria. Mitochondrial cAMP signaling is an
indispensable part of the cytoplasm-mitochondrion crosstalk
that maintains mitochondrial homeostasis, regulates mito-
chondrial dynamics, and modulates cellular stress responses
and other signaling pathways. Recently, the compartmen-
talization of mitochondrial cAMP signaling has attracted
great attentions. This new input should be carefully taken
into account when we interpret the findings of mitochondrial
cAMP signaling. In this review, we summarize previous and
recent progress in our understanding ofmitochondrial cAMP
signaling, including the components of the signaling cas-
cade, and the function and regulation of this signaling
pathway in different mitochondrial compartments.
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sAC Soluble adenylyl cyclase
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PLC Phospholipase C
PKC Protein kinase C
PI3K Phosphoinositide 3-kinase
IP3 Inositol trisphosphate
PDE Cyclic nucleotide phosphodiesterase
AKAP A-kinase anchoring protein
IMS Intermembrane space
IMM Inner mitochondrial membrane
TOM Translocase of the outer membrane
AAC ADP/ATP carrier
MDV Mitochondrion-derived vesicles
Drp1 Dynamin-related protein 1
Mfn2 Mitofusin 2
OPA1 Optic atrophy 1
MAPK Mitogen-activated protein kinases
GSK-3b Glycogen synthase kinase 3b
SKIP Sphingosine kinase interacting protein
FRET Fluorescence resonance energy transfer
TCA Tricarboxylic acid





COXIV-1 Cytochrome c oxidase subunit IV isoform 1
COX Cytochrome c oxidase
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ROS Reactive oxygen species
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PGC-1a Peroxisome proliferator-activated receptor
gamma co-activator 1a
NRF Nuclear respiratory factor




Mitochondria, unique organelles enclosed by a two-layered
membrane, produce the majority of cellular ATP in the
eukaryotic cells through oxidative phosphorylation
(OXPHOS). They also house the biosynthetic processes for
many of the cell’s building blocks, including lipids,
nucleotides, amino acids, and heme. Besides their well-
recognized roles in energy and intermediate metabolism,
mitochondria are now accepted as an important nexus for
signaling cascades involved in cell growth, proliferation,
differentiation and death [1].
Mitochondria originated from the endosymbiosis of
ancestral bacteria inside primitive eukaryotic cells,
approximately two billion years ago [1, 2]. Over their long
evolutionary history, the engulfed bacteria ceased to
function as free-living organisms, becoming instead semi-
autonomous organelles. The majority of the mitochondrial
ancestor’s genetic content was either lost or transferred to
the host nuclear genome [3], and only a small fraction was
retained in mitochondria. A typical animal cell contains
hundreds to thousands copies of mitochondrial DNA
(mtDNA), each encoding 13 essential subunits of the
electron transport chain (ETC), 2 ribosomal RNAs and 22
tRNAs required for protein synthesis inside the organelle.
The majority of the approximately 1500 mitochondrial
proteins are encoded by the nuclear genome, synthesized in
the cytoplasm and imported into mitochondria after trans-
lation [4, 5].
Mitochondria cannot be produced de novo. Instead, their
proliferation requires mtDNA replication and the addition
of lipids and proteins to the existing organelles [6, 7].
Mitochondria also undergo constant fusion and fission to
adjust their shape and numbers in cells [8, 9]. Fusion and
fission are also critical for the positioning, movement and
even destruction of mitochondria. Mitochondrial biogene-
sis (the growth and division of pre-existing mitochondria)
and dynamics (movement and morphological changes) are
highly plastic in response to the cell’s energy demand, to
developmental cues and to environmental stimuli. The
success of such symbiosis requires carefully orchestrated
communications between the eukaryocyte host and the
prokaryocyte organelle. In the past a few years, it has
become apparent that these communications are mediated
in great part by cAMP signaling, a universal pathway
conserved in all cellular organisms.
In this review, we briefly describe the compartmental-
ized landscape of mitochondrial cAMP signaling and
discuss its regulation and diverse functions. We summarize
the established roles of cAMP-PKA signaling the outer
mitochondrial membrane (OMM) in protein import, mito-
chondrial fission and apoptosis. We also discuss the recent
evidence for cAMP signaling in the mitochondrial matrix,
as well as its effectors in the regulation of OXPHOS and
mitochondrial biogenesis. In addition, we present unre-
solved questions about intra-mitochondrial cAMP
signaling that need to be addressed in the future. Finally,
we speculate on the therapeutic potential of managing
mitochondrial cAMP signaling for diseases linked to
mitochondrial deficiencies.
Cellular cAMP signaling
and compartmentalization (Fig. 1)
cAMP, one of the first identified and most versatile second
messengers, mediates diverse cellular responses to extra-
cellular signals. Over the past decades, various mechanisms
triggering the production of cAMP have been identified, as
well as its downstream effectors. Upon the activation of
membrane receptors, downstream transducers, mainly G
proteins, activate adenylyl cyclases on the plasma membrane
(TmACs) to convert ATP to cAMP [10, 11]. Intracellular
cAMP can also be produced by soluble adenylyl cyclases
(sACs) in response to bicarbonate, calcium and the change
of ATP level [12–15]. The major downstream effector of
cAMP signaling is protein kinase A (PKA), a heterotetramer
consisting of two catalytic subunits and two regulatory
subunits. cAMP binds to the regulatory subunits, which
releases and activates the catalytic subunits [16, 17]. Acti-
vated PKA phosphorylates and activates cAMP response
element (CRE)-binding protein (CREB), a transcriptional
co-factor that initiates an array of transcriptional cascades
involved in immune response, cellular metabolism and
mitochondrial biogenesis [18–20]. Besides its role in tran-
scriptional regulation, PKA phosphorylates and modulates
the activity of ion channels [21–23], cellular motor proteins
[24, 25] and many enzymes involved in intermediate
metabolism [26]. Many signaling and regulatory proteins,
such as phospholipase C (PLC) [27], protein kinase C (PKC)
[28], phosphoinositide 3-kinase (PI3K) [29, 30] and inositol
trisphosphate (IP3) receptors [31], are also regulated by
PKA-dependent phosphorylation. These phosphorylation
events intertwine cAMP-PKA signaling with other cellular
messengers and signaling cascades, and provide multiple
feedback loops further modulating cAMP signaling [32, 33].
Intracellular cAMP level is regulated by the balanced act of
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ACs and cyclic nucleotide phosphodiesterases (PDEs),
which terminate cAMP-PKA signaling by hydrolyzing
cAMP to AMP [34, 35]. Besides the main effector PKA,
cAMP can also directly activate the exchange protein Epac
[36], the cyclic nucleotide-gated channels [37] and the
Popeye domain-containing proteins [38, 39]. Within a single
cAMP cascade, ACs, PKA, other downstream effectors and
PDEs are often tethered together by scaffold proteins, the
A-kinase anchoring proteins (AKAPs), at distinct subcellular
locations [16, 40]. The compartmentalization of these sig-
naling proteins [41–44] not only promotes the efficiency of
cAMP signaling transduction, but also allows the same
second messenger, cAMP, to mediate diverse physiological
responses.
The compartmentalized structure of mitochondria [45]
further shapes the cAMP signaling profile. The cAMP
produced by TmAC or sAC in the cytosol can freely dif-
fuse to the outer mitochondrial membrane (OMM) and
activate the local PKAs at the mitochondrial surface.
Moreover, as the OMM is readily permeable to ions and
small molecules of 5 kDa or less [46], cytosolic cAMP
might also regulate pathways inside the inter-membrane
space (IMS). The inner mitochondrial membrane (IMM),
however, is intrinsically impermeable due to a lack of
Porins [47] and a high content of cardiolipin [48]. Never-
theless, cAMP is detected in the mitochondrial matrix of
metazoans [49], which raises the questions of its origin in
the matrix, and of its potential role in the regulation of
biochemical pathways in this compartment.
cAMP signaling in the outer-mitochondrial
compartment (Fig. 2)
Metabolic switch and mitochondrial protein import
As the interface between mitochondria and cytosol, the




































Fig. 1 General cAMP signaling pathways. Intracellular cAMPs are
generated by two classes of ACs, the transmembrane AC (TmAC) and
the soluble AC (sAC). Both TmAC and sAC convert ATP to cAMP
upon stimulus. TmAC can be activated by G proteins when an
extracellular signal is received by the G protein-coupled membrane
receptor. sAC is insensitive to G-proteins but can be activated by
bicarbonate and calcium. Elevated cAMP level activates protein
kinase A (PKA), the major effector of cAMP signaling, by releasing
the two catalytic subunits (Cs) from the two regulatory subunits (Rs).
Activated PKA in turn phosphorylates and activates numerous
downstream protein targets, including the cAMP response element
binding protein (CREB), a transcriptional co-factor regulating
multiple cellular processes. Cyclic nucleotide phosphodiesterases
(PDEs) are the negative regulators that terminate cAMP-PKA
signaling by hydrolyzing cAMP to AMP. As a result, cAMP level
and signaling activity are determined by the equilibrium between ACs
and PDEs. In addition to its main effector PKA, cAMP can also
directly activate the exchange protein Epac, the cyclic nucleotide-
gated channels (CNGCs) and the Popeye domain-containing proteins
(Popdcs). Within a single cAMP cascade, ACs, PKA, other down-
stream effectors and PDEs are often tethered together by an A-kinase
anchoring proteins (AKAPs) at distinct subcellular locations
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signaling messengers regulating mitochondrial biogenesis,
morphology and removal. Mitochondrial biogenesis entails
the synthesis of approximately 1500 nucleus-encoded
polypeptides in the cytoplasm and their import to mito-
chondria [4, 5]. The translocase of the outer membrane
(TOM) complex represents the predominant pathway for
importing proteins across the OMM [4, 5]. It is also one of
the main downstream effectors of cAMP-PKA signaling
tuning mitochondrial biogenesis to metabolism [50]. Three
core components of the TOM complex, TOM70, TOM22
and TOM40, are phosphorylated by PKA in response to the
glucose-induced cAMP increase triggered by a metabolic
switch from respiratory to fermentable conditions [51–53].
Phosphorylation by PKA impairs the interaction between
TOM70 and metabolite carrier/chaperone complexes (e.g.,
AAC/Hsp70) [51], inhibits the translocation of TOM22 to
mitochondria [52] and prevents the integration of TOM40
into the OMM [53]. Thus, elevated cAMP-PKA signaling
slows down the import of mitochondrial proteins, and
fosters the metabolic switch from OXPHOS to glycolysis
in conditions of increased glucose or reduced oxygen
availability.
Stress response and regulation of mitochondrial
fission and fusion
Mitochondrial fission and fusion are indispensable for
mitochondrial homeostasis [8, 9]. In a pool of overall
healthy mitochondria, fusion mingles proteins, lipids and
metabolites among individual mitochondria, thereby miti-
gating the defects of dysfunctional ones. On the other hand,
fission enables the segregation of damaged mitochondria
from a healthy population for their eventual removal, pos-
sibly through autophagy and mitochondrion-derived vesicles
(MDV) [54–56]. Unbalanced fusion and fission can impair
mitochondrial biogenesis, cause excessive mitochondrial
fragmentation and trigger apoptosis [8, 9]. Elevated cAMP
signaling upon bioenergetic stresses like starvation can
inhibit mitochondrial fission, suspend unnecessary biogen-




































Fig. 2 cAMP signaling in the outer-mitochondrial compartment.
cAMP from the cytosol or produced by sAC on the OMM can activate
the local PKA which in turn phosphorylates different targets
associated with the OMM. a PKA phosphorylation impairs the
receptor activity of TOM70 and its interaction with the metabolite
carrier/chaperone, prevents TOM22 translocation and TOM40 inte-
gration into the OMM, and eventually slows down the import of
mitochondrial proteins. b PKA phosphorylation can also block Drp1’s
translocation to the OMM surface and thus lead to reduced
mitochondrial fission. c In mammals, PKA phosphorylation inhibits
Bad’s apoptotic activity but promotes Bim’s by increasing its stability
against proteasome-dependent degradation. PKA phosphorylation of
Bax promotes its translocation to mitochondria and triggers the
release of cytochrome c (CC) and the maturation of the apoptosome,
which eventually leads to apoptosis. AKAPs tether PKA and other
proteins, e.g., Bad, on the OMM to facilitate the cAMP-PKA
targeting. They also promote different signaling specificities under the
same environmental context by providing a dynamic platform of
proteins complex in multiple combinations
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boosting energy metabolism [57]. Mitochondrion fission is
mediated by the dynamin-like GTPase, Drp1, which is
recruited to the mitochondrial surface and assembled into a
multimeric ring-like structure wrapping around the con-
striction points of the dividing mitochondria [58].
Phosphorylation of Drp1 by PKA blocks its translocation to
the mitochondrial surface, leading to mitochondrial elon-
gation rather than fission, which promotes cell survival
[57, 59–61]. Reciprocally, Drp1 de-phosphorylation facili-
tates Drp1 recruitment to mitochondria and promotes fission,
autophagy and apoptosis [54, 59, 62].
Under conditions of increased autophagy, a feedback
response can promote fusion and survival by activating
cAMP-PKA-dependent Drp1 phosphorylation and mito-
chondria elongation [57]. In addition to Drp1, PKA can
also phosphorylate mitofusin 2 (Mfn2) [63] and bind to
optic atrophy 1 (OPA1) [64, 65]. Both Mfn2 and OPA1 are
involved in mitochondrial fusion [9]. However, the physi-
ological significance of cAMP-PKA signaling in regulating
mitochondrial fusion remains elusive.
Apoptosis
Several apoptosis-related proteins are substrates of PKA
[66–73]. In mammals, the intrinsic apoptotic pathway is
regulated by the concerted action of anti-apoptotic Bcl-2
like proteins and pro-apoptotic BH3-only proteins [74, 75].
The pro-apoptotic proteins Bax [68, 69], Bad
[66, 67, 70, 71] and Bim [72] can all be phosphorylated by
PKA. However PKA phosphorylation on these proteins
have completely opposite consequences: IL3-induced PKA
phosphorylation of Bad inhibits its apoptotic activity [66],
and the effect is mediated through the formation of PKA-
Bad complex on the OMM [67, 70, 71]. By contrast, PKA
phosphorylation of Bax promotes its translocation to
mitochondria and triggers cytochrome c release and
apoptosis [68, 69]. In addition, PKA phosphorylation of an
isoform of Bim increases its stability against proteasome-
dependent degradation and promotes its apoptotic effect
[72].
AKAPs as mediators of cAMP signaling specificity
on the OMM
It is perplexing that a common messenger, cAMP, can
elicit such diverse and distinct responses through different
effectors on the OMM. It is now recognized that a family
of PKA-anchoring proteins, the AKAPs, bind to and target
PKA to distinct subcellular locations including the mito-
chondrial surface, the plasma membrane and the nucleus
[16, 40]. AKAPs also act as scaffold proteins that tether
PKA, PDEs, phosphatases, cytoskeleton proteins as well as
other signaling molecules, such as PKC, MAPK, GSK-3b
together, to form multi-protein signaling complexes
[16, 40, 76–79]. Multiple AKAP isoforms have been found
localized to mitochondria in metazoan [76, 78–86], and
most AKAPs localize to the OMM. Specifically, D-AKAP1
has been proved directly siting in the OMM with its
C-terminus protruding into the cytoplasm [87, 88]. The
OMM-bound AKAPs tether PKA and other signaling
molecules on the OMM [66, 78, 79, 84, 89–92]. This
spatial organization allows the signaling specificities of
different PKA pathways with a shared common messenger,
cAMP, and thereby supports versatile combinations of
mitochondrion related regulations. The sphingosine kinase
interacting protein (SKIP) is an exceptional AKAP that
recruits PKA to the IMS and the matrix of murine heart
mitochondria [86].
cAMP signaling inside the matrix (Fig. 3)
Mitochondrial biogenesis relies on the coordination
between mitochondrial and nuclear genomes [6, 7]. In
particular, the assembly of ETC complexes and mito-
chondrial ribosomes require the proper stoichiometry of
nucleus- and mitochondria-encoded components. Mito-
chondria originated from bacteria, and bacteria use cAMP
signaling to regulate motility, metabolism and DNA
replication [93]. One can therefore speculate that a local
cAMP signaling might have been retained in the mito-
chondrial matrix during evolution even though most
mitochondrial components became encoded in the nuclear
genome. Considering the emerging roles of cAMP signal-
ing in the regulation of nuclear transcriptional activity and
protein import into mitochondria, it is conceivable that
cAMP signaling might act in parallel inside the matrix to
modulate mitochondrial activities locally. Indeed, accu-
mulating evidence supports a role for cAMP signaling
inside the matrix as a necessary complement to the nuclear
regulation.
Origin of cAMP in the mitochondrial matrix
Although cAMP per se cannot freely diffuse across the
IMM from the cytosol, both biochemical assays with iso-
lated mitochondria [94, 95] and live-cell experiments using
genetic reporters [49, 96, 97] have demonstrated the pres-
ence of cAMP inside mammalian mitochondria. However,
the origin of matrix cAMP is still debated. After a brief
incubation with purified mitochondria in vitro, cAMP
readily accumulates in the mitochondrial matrix, suggest-
ing that it could be actively transported into the matrix
[94]. But recent studies using genetic cAMP reporters in
cultured human cell lines (Hela, HEK293T) and primary
rat cardiomyocytes argue that mitochondrial inner
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membrane is impermeable to cAMP [96, 97]. A model for
generating cAMP locally has hence been proposed. It
involves a mitochondrially localized sAC that can be
directly activated by HCO3
- [12] and was shown to syn-
thesize cAMP locally in response to the CO2/HCO3
-
produced in the TCA cycle in mammalian cultured cells
[95–100]. The matrix CO2-sAC-cAMP-PKA cascade is
also involved in the allosteric regulation of COX activity
by ATP in the S. cerevisiae, demonstrating a conserved
role of cAMP signaling in fine-tuning energy metabolism
[101]. However, the Drosophila and C. elegans genomes
do not encode any known sAC [102], and the prevalence of
intra-mitochondrial cAMP signaling in metazoans has been
called into question.
We recently constructed a matrix-localized cAMP sen-
sor by fusing the new generation of cAMP reporter,
ICUE3, with SOD2, a bona fide mitochondrial matrix
protein [103]. Using this construct, we demonstrated the
existence of cAMP in the mitochondrial matrix of Droso-
phila cultured cells. Given the lack of sAC in the fly
genome, our finding suggests that an unidentified mecha-
nism allows the rapid entry of cytosolic cAMP into the
mitochondrial matrix, which is consistent with a previous
biochemical study [94]. Still, the Drosophila genome
contains 14 genes that encode 38 different AC isoforms
(http://flybase.org/). We thus cannot rule out the possibility
that a matrix AC might be among them and produce cAMP
locally. Although the sources of matrix cAMP may differ
in different organisms and cell types, the presence of
cAMP in the mitochondrial matrix now appears universal.
PKA as the main effector of cAMP signaling
in the mitochondrial matrix
Protein kinase A has long been considered as the main
effector of intra-mitochondrial cAMP to regulate mito-
chondrial energy metabolism [95, 96, 104–107]. Large-
scale phosphoproteome analyses revealed that many
enzymes in the TCA cycle and ETC complex subunits were
phosphorylated at the PKA consensus sites [108, 109].
These observations suggest that PKA is one of the most
active kinases in the matrix [108, 109]. In support of this
idea, 85 % of PKA activity associated with purified mito-


































Fig. 3 cAMP signaling in the mitochondrial matrix. The intra-
mitochondrial cAMP-PKA pathway has been proposed to fine-tune
metabolism by directly regulating the TCA cycle and respiration.
sACs have been found in the mitochondrial matrix and produce
cAMP locally in response to the CO2/HCO3
- generated by the TCA
cycle. The matrix cAMP-PKA cascades are then activated, leading to
the phosphorylation of ETC proteins such as Complex I and Complex
IV subunits, modulating the OXPHOS and ATP production. In
addition, PKA phosphorylation of the ATPase inhibitory factor 1
(IF1) abolishes its ability to bind to and inhibit Complex V. The sACs
can also be activated by mitochondrial uptake of Ca2?. Active
mechanisms for transporting cAMP into the matrix remain to be
identified. To coordinate the OXPHOS and energy needs, the cAMP-
PKA pathways outside mitochondria can activate the nuclear CREBs
and the downstream transcription factors (PGC-1a, NRF) to promote
TFAM (mtTFA) production, mtDNA replication and eventually
mitochondrial biogenesis. On the other hand, the matrix cAMP
signaling could exert a negative regulation on this process by
increasing the PKA phosphorylation-dependent degradation of TFAM
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[110]. However, FRET-based PKA activity reporters that
are targeted to the mitochondrial matrix do not respond to
the addition of membrane-permeable cAMP analogs or
bicarbonate [97]. It has been argued that the phosphory-
lation of matrix proteins at PKA consensus sites might take
place before their import to the matrix [97]. We have
developed a bimolecular fluorescence complementation
(BiFC) assay for assessing the submitochondrial localiza-
tion of proteins [103]. The assay is based on the fact that
two halves of a GFP molecule will reconstitute into a
whole, fluorescent GFP molecule only when they are in
physical proximity [111]. By applying this sensitive assay,
we demonstrated that PKA indeed locates to the mito-
chondrial matrix [103], substantiating the presence of local
cAMP-PKA signaling.
Other members of the cAMP signaling pathway
in the matrix
Besides the sACs and PKA, other components of cAMP
signaling cascade have also been identified in the matrix,
including cAMP PDE activity proteins such as PDE2A2
[100] and Prune [103]. Interestingly, PDEs can be inhibited
by hydrogen sulfide (H2S), which is produced in the matrix
by enzymes such as 3-mercaptopyruvate sulfurtransferase
(3-MST), cystathionine b-synthase (CBS) and cystathion-
ine g-lyase (CSE) in response to environmental stresses
like hypoxia [112]. These findings suggest a potential link
between the environmental stresses and cAMP signaling in
the mitochondrial matrix. In summary, almost a full com-
plement of key components of the cAMP signaling cascade
(CO2/HCO3
-, Ca2?, sAC, cAMP, PKA, PDE and H2S) has
been identified in the matrix, strongly supporting the
existence of a distinct cAMP signaling in the mitochondrial
matrix, which may have specific physiological and patho-
logical implications.
Intra-mitochondrial cAMP signaling regulates
OXPHOS
A rich body of literature has documented the phosphory-
lation of ETC complexes and enzymes in the TCA cycle by
PKA [95, 104–109, 113–116]. This observation suggests
that the cAMP-PKA pathway in the matrix may fine-tune
metabolism by directly regulating the TCA cycle and res-
piration. A rise in CO2 or bicarbonate concentration is
thought to activate a matrix-localized sAC. The sAC pro-
duces cAMP locally, which in turn activates PKA and leads
to phosphorylation of cytochrome c oxidase subunit IV
isoform 1 (COXIV-1), resulting in enhanced cytochrome
c oxidase (COX) activity and OXPHOS [95]. In yeast, a
similar phosphorylation-dependent regulation on Cox5a,
the homolog of COXIV-1, has also been reported [101].
Evidences also suggest that PKA can phosphorylate sub-
units of Complex I, which increases Complex I activity and
stability, and hence enhances respiration
[107, 113, 117–122]. Given that CO2 is the end product of
the TCA cycle, the cAMP-PKA pathway provides a feed-
forward regulation on two modules of energy metabolism:
TCA cycle and ETC complexes. Recently, Complex V
activity has also been found under the regulation of matrix
cAMP-PKA pathway [123–125]. Complex V (mitochon-
drial ATP synthase) catalyzes the synthesis of ATP through
the proton gradient generated by the ETC complexes and
executes the reverse hydrolysis when the membrane
potential falls below a threshold (pH of *6.7 or below)
[126]. An ATPase inhibitory factor 1 (IF1) is thought to act
as a ‘‘reverse rotation brake’’ for the ATP synthase motor,
preventing the ‘‘wasteful’’ ATP hydrolysis under the
anaerobic condition [126, 127]. A recent study demon-
strated that IF1 binds to Complex V and inhibits not only
its hydrolase but also its ATP synthase activity [123]. IF1
can be phosphorylated by PKA, which prevents it from
binding to Complex V, and thereby relieves its inhibitory
effects on both the hydrolytic and synthetic activities of
Complex V [123]. Thus the phosphorylation status of IF1
appears to be key in regulating the flux of glycolysis and
OXPHOS corresponding to certain physiological context
[124]. Furthermore, De Rasmo and colleagues recently
have demonstrated the importance of the sAC-cAMP sig-
naling for the organization and activity of Complex V in
isolated rat mitochondria and myoblast cultures [125].
The impact of PKA on ETC complexes appears to be
multifaceted depending on the environment cues. Under
hypoxia/ischemia condition, excess of reactive oxygen
species (ROS) induces the sequestration of PKA catalytic a
subunit into the matrix, and leads to the hyper-phosphory-
lation of Complex IV and reduced COX activity [114, 128].
PKA phosphorylation on several Complex IV subunits dur-
ing heart failure may also inhibit OXPHOS by either
disrupting the complex assembly or reducing its stability
[129]. Taken together, the intra-mitochondrial cAMP-PKA
signaling may serve as an acute and local mechanism
allowing mitochondria to rapidly adjust energy output in
response to environmental stress, and to oxygen and nutrient
availability. Under the aerobic condition, the steady stream
of CO2 produced from TCA cycle activates sAC-cAMP-
PKAcascade, which in turn tunes up the activities of the ETC
complexes by coordinating TCA cycle and ETC complexes.
While CO2 production is diminished under metabolic or
environmental stress, ROS can directly activate PKA to
inhibit ETC complexes to avoid excessive ROS production.
Of note, Ca2? can also activate sAC, the principal source of
matrix cAMP [96], highlighting a potential crosstalk and
synergy between these two common second messengers
(cAMP and Ca2?) in regulating energy metabolism.
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Intra-mitochondrial cAMP signaling regulates
mitochondrial biogenesis
Regulating OXPHOS is not the only way through which
mitochondria respond to the cellular and environmental
cues. A long-term adaptation of energy homeostasis can be
achieved by modulating mitochondrial biogenesis. As
previously described, during stresses such as hypoxia and
starvation, the cAMP-PKA pathway can suppress mito-
chondrial biogenesis by inhibiting protein import and
mitochondrial fission. On the other hand, the cytosolic
cAMP-PKA pathway can also activate the nuclear CREBs
and the downstream transcription factors (PGC-1a, NRF),
which in turn activates the transcription of mitochondrial
transcription factor A (mtTFA, also abbreviated as TFAM)
and mitochondrial biogenesis [6, 130]. CREBs are also
found inside mitochondria, binding to the CREs on the
mtDNA D-loop, and directly regulating mtDNA-encoded
gene expression [131–134]. The translocation of CREBs
into mitochondria may be facilitated by chaperones like
mtHsp70 [132] or by a process that depends on both
membrane potential and TOM complex [134]. Both nuclear
and mitochondrial CREB pathways promote neuronal
survival in the brain [132, 133, 135], which is consistent
with their positive roles in mitochondrial biogenesis.
Matrix cAMP signaling could also exert negative reg-
ulations on mitochondrial biogenesis. Human mtTFA can
be phosphorylated by PKA, leading to decreased mtTFA-
mtDNA interaction and increased mtTFA degradation
[136]. Recently, we confirmed such phosphorylation in
Drosophila and found that Prune, a mitochondrial PDE,
stabilizes mtTFA by down-regulating cAMP levels in the
mitochondrial matrix, thereby promotes mtDNA replica-
tion [103]. It thus appears the cAMP-PKA signaling acts
as a ‘‘double agent’’ to fine-tune the mtTFA level. It
promotes the expression of nuclear-encoded mtTFA,
while counterbalances this action by negatively modulat-
ing mtTFA protein level through PKA-dependent
degradation in the mitochondrial matrix. Our finding
demonstrates the prevalence of mitochondrial matrix
cAMP signaling and provides a new insight into its role
in coordinating nuclear and mitochondrial regulation on
mitochondrial biogenesis.
Future perspectives
Remaining mysteries in the mitochondrial cAMP
signaling pathways
The repertoire of cAMP-PKA signaling components iden-
tified both on the OMM and in the mitochondrial matrix is
growing. New regulations on mitochondrial functions by
cAMP-PKA signaling keep emerging. We now recognize
that cAMP signaling can respond to extracellular stimuli,
intracellular cues or even environmental stresses to mod-
ulate a variety of mitochondrial behaviors including energy
homeostasis, mitochondrial biogenesis and cell death. The
literature also demonstrates the great complexity of mito-
chondrial cAMP signaling. The compartmentalization of
mitochondrial cAMP signaling ensures its specificity. PKA
phosphorylation on the same protein under different envi-
ronmental or physiological context can lead to distinct,
even opposite functional consequences, further demon-
strating the complexity of mitochondrial cAMP signaling.
Meanwhile, cAMP signaling pathway in different mito-
chondrial compartments (the OMM and the matrix) can
work synergistically, and may interact with cytosolic and
nuclear cAMP signaling to achieve coordinated and bal-
anced regulations on mitochondrial functions.
The discovery of intra-mitochondrial cAMP signaling in
Drosophila not only demonstrates the prevalence of mito-
chondrial cAMP signaling in metazoan, but also reveals an
unknown regulation on mitochondrial biogenesis. However
the lack of sACs in Drosophila and C. elegans genomes
[102] presents an unsettled issue regarding the source of
mitochondrial cAMP in these organisms. It is worth
exploring whether there are unidentified AC isoforms that
localize to mitochondria in these species. Meanwhile it
remains to be determined whether there is indeed an active
transport mechanism for cAMP into the matrix.
It is noteworthy that ATP-binding cassette (ABC)
transporters have been found to work synergistically with
PDEs regulating both local and global cAMP level
[137, 138]. Recently one of the ABC B subfamily members
has been shown to export cAMP in D. discoideum [139].
Several evolutionarily related ABC B subfamily proteins
have been found localized on the IMM [140, 141]. It would
be interesting to test whether any of these ABC transporters
might contribute to the matrix cAMP transport.
sACs can be activated by direct Ca2? binding in a dose-
dependent manner [13], demonstrating a potential crosstalk
between these two most common second messengers
[32, 142, 143]. In cells that lack the active transporting
mechanism for cAMP into the matrix, Ca2? may relay the
cytosolic cAMP signaling to the matrix and activate sAC
wherein [96]. Thus the intra-mitochondrial Ca2? and
cAMP signaling may act synergistically in regulating
energy metabolism [15, 32, 96, 144]. Whether Ca2?, or
other messengers, affords coordination between cytosolic
and intra-mitochondrial cAMP signaling, awaits further
investigation. And to what extent a crosstalk between
cAMP and other signaling is achieved to regulate mito-
chondrial behaviors remains to be explored.
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Potential applications to the treatment
of mitochondrial dysfunction diseases
Given the essential role of mitochondrial cAMP signaling
in mitochondrial dynamics, biogenesis and metabolism, it
is not surprising that its misregulation can cause various
disorders, particularly in cells and tissues with high-energy
demand. For instance, displacement of AKAP121 increases
ROS production, induces apoptosis and triggers cardiac
hypertrophy in transgenic rodents [145]. Loss of AKAP
and decline of mitochondrial PKA signaling are believed to
contribute to the etiology of several brain degenerative
disease models [146]. In Drosophila, the misregulation of
the intra-mitochondrial cAMP signaling impairs mito-
chondrial biogenesis and triggers neurodegeneration [103].
On the other hand, manipulating mitochondrial cAMP
signaling might provide a handle to modulate energy
metabolism and control cell death, thereby offering
potential avenues for managing mitochondrial diseases and
neuromuscular diseases associated with mitochondrial
dysfunctions. Several compounds that modulate cAMP-
PKA signaling globally, including PDE inhibitors and PKA
inhibitors (H89), have shown promise in treating inflam-
mation, diabetes and cardiovascular disorders
[35, 147, 148]. However, their application to modulating
mitochondrial cAMP signaling locally has to be cautioned.
In particular, specific delivery of drugs into mitochondrial
compartments is necessary to avoid broad activation or
inhibition of cellular cAMP signaling. A lipophilic cation,
triphenylphosphonium (TPP?), which preferentially accu-
mulates in the mitochondrial matrix can effectively target
antioxidants and metabolic-modulating compounds to
mitochondria [149]. Peptides containing a unique aromatic-
cationic sequence motif also concentrate on the mito-
chondria inner membrane [149, 150]. It would be
interesting to test whether these molecules can be used to
deliver cAMP signaling-modulating compounds to specific
mitochondrial compartments, and thereby to improve
mitochondrial functions without interfering with other
cAMP signaling processes.
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